Need advice in managing cancer immunotherapy cardiotoxicity?

Request Assistance
Providers Bevacizumab


Trade Name



VEGFR-targeted antibody

Cancer Indication

Colorectal cancer, non-squamous non-small cell lung cancer, glioblastoma, renal cell carcinoma, cervical cancer, epithelial ovarian, fallopian tube, primary peritoneal cancer

Cardiotoxic Side Effects

Hypertension Vascular (Arterial and venous) Heart Failure Metabolic (hyperglycemia) Hypertension (12% to 34%; grades 3/4: 5% to 18%), thromboembolism (≤21%; grades 3/4: 15%; venous thromboembolism: 8%; grades 3/4: 5% to 7%; arterial thrombosis 6%; grades 3/4: 3%), hypotension (7% to 15%)